The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-{[2-Ethyl-10-oxo-9,10-dihydroanthracene-9-ylidene]amino}benzoicacid ID: ALA2283225
PubChem CID: 76330905
Max Phase: Preclinical
Molecular Formula: C23H17NO3
Molecular Weight: 355.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccc2c(c1)/C(=N/c1cccc(C(=O)O)c1)c1ccccc1C2=O
Standard InChI: InChI=1S/C23H17NO3/c1-2-14-10-11-19-20(12-14)21(17-8-3-4-9-18(17)22(19)25)24-16-7-5-6-15(13-16)23(26)27/h3-13H,2H2,1H3,(H,26,27)/b24-21+
Standard InChI Key: WEJDWBALHUTSBL-DARPEHSRSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
22.6947 -3.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6936 -4.1274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4126 -4.5445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1290 -4.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1262 -3.2922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4107 -2.8830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8432 -2.8770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8402 -2.0478 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9802 -2.8835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5588 -3.2878 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9800 -2.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9893 -0.4077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7020 -0.8239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6978 -1.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4083 -2.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1237 -1.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1240 -0.8256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4128 -0.4153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2696 -1.6468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2735 -0.8151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5633 -0.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8490 -0.8110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8492 -1.6386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5598 -2.0548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1335 -2.0490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4202 -1.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9939 0.4174 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
1 9 1 0
7 10 1 0
9 11 2 0
11 14 1 0
11 19 1 0
13 12 1 0
12 20 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
23 25 1 0
25 26 1 0
12 27 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.39Molecular Weight (Monoisotopic): 355.1208AlogP: 4.66#Rotatable Bonds: 3Polar Surface Area: 66.73Molecular Species: ACIDHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.59CX Basic pKa: 0.70CX LogP: 5.70CX LogD: 2.96Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.58Np Likeness Score: -0.39
References 1. Bansal SK, Sinha BN, Khosa RL. (2013) -Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation, 22 (1): [10.1007/s00044-012-0023-0 ]